Management of hypothyroidism with combination thyroxine (T4) and triiodothyronine (T3) hormone replacement in clinical practice: a review of suggested guidance

Overview of attention for article published in Thyroid Research, January 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#24 of 219)
High Attention Score compared to outputs of the same age (81st percentile)

Mentioned by

twitter: 15 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 41 Dimensions

Readers on

mendeley: 91 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 16 X posts from 15 X users, with an upper bound of 43,605 followers.

@MALSWAR https://t.co/s3KiUbADxK https://t.co/YYV5YyIH2C

Reply Repost Favourite

RT @gmacscotland: T3 or not T3? Really interesting debate on treatment of hypothyroidism at #rcpeDiabetes19 Cost of T3 has increased mass…

Reply Repost Favourite

T3 or not T3? Really interesting debate on treatment of hypothyroidism at #rcpeDiabetes19 Cost of T3 has increased massively in UK. Clinical evidence for combined T3/T4 therapy limited. Read more: https://t.co/VxN6V6HgZx https://t.co/dd73jgMvdX

Reply Repost Favourite

@Marangus77 Also, in this paper they concluded a slow-release T3 would be optimal, but acknowledge that there was nothing with a reliable dose yet on the market. https://t.co/ihYhIiHn9Z https://t.co/4ce7aPkQ7W

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 12 additional X posts.